Impact of Delayed Infusion on Safety and Efficacy of Anti-CD19 and Anti-BCMA CAR T-Cell Therapies

Blood Immunology & Cellular Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles